Effect of rituximab on humanin vivoantibody immune responses

Background B-lymphocyte depletion with rituximab has been shown to benefit patients with various autoimmune diseases. We have previously demonstrated that this benefit is also apparent in patients with newly diagnosed type 1 diabetes. Objectives The effect of rituximab onin vivoantibody responses, p...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Journal of allergy and clinical immunology 2011-12, Vol.128 (6), p.1295
Hauptverfasser:	Pescovitz, Mark D, Torgerson, Troy R, Ochs, Hans D, Ocheltree, Elizabeth, McGee, Paula, Krause-Steinrauf, Heidi, Lachin, John M, Canniff, Jennifer, Greenbaum, Carla, Herold, Kevan C, Skyler, Jay S, Weinberg, Adriana
Format:	Artikel
Sprache:	eng
Schlagworte:	Age Colleges & universities Diphtheria Drug dosages Hepatitis Immune system Lymphocytes Measles Mumps Tetanus Vaccines
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!